Literature DB >> 23494083

Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome.

Francesca Ratti1, Federica Cipriani, Fabio Ferla, Marco Catena, Michele Paganelli, Luca A M Aldrighetti.   

Abstract

INTRODUCTION: The diagnosis and treatment of hilar tumors requires a multidisciplinary approach based on the synergy of radiologists, surgeons, oncologists, and gastroenterologists. Klatskin tumor is a relatively rare disease with a poor prognosis. Currently, the only possible treatment is represented by the removal of the tumor associated with radical surgery, even though its results are still jeopardized by significant morbidity and mortality. A proper preoperative optimization of the patient, including staging laparoscopy, biliary drainage, and portal vein embolization, may improve short-term outcome. The purpose of this study was to evaluate the short- and long-term impact of preoperative optimization in patients affected by hilar cholangiocarcinoma.
METHODS: From January 2004 to May 2012, 94 patients with preoperative diagnosis of Klastkin tumors were candidates for surgery at the Hepatobiliary Surgery Unit of the Hospital San Raffaele in Milan. The data of all patients were prospectively collected and retrospectively reviewed. The outcome was evaluated in terms of perioperative morbidity and mortality and overall and disease-free survival. Short-term outcome of patients undergoing preoperative optimization was compared with outcome of patients who did not undergo it in terms of intraoperative data, morbidity and mortality.
RESULTS: Of 94 patients undergoing surgery, 80 underwent hepatic and biliary confluence resection. Fourteen patients were considered unresectable due to the presence of peritoneal carcinomatosis or advanced disease seen during staging laparoscopy or at laparotomy and therefore were excluded from the analysis. Seventy-five (93.7 %) patients underwent major liver resections: in 14 of these, surgery was performed at a distance of 30-40 days from PVE. In 55 patients, biliary drainage was preoperatively placed for palliation of obstructive jaundice. The postoperative morbidity rate was 51.2 % and mortality 6.2 %. The most frequent cause of death was postoperative liver failure. Five-year survival rate was 29 %. Patients undergoing preoperative optimization experienced a significant reduction of postoperative morbidity, especially in terms of infectious related events.
CONCLUSIONS: Klatskin tumor remains a disease associated with poor prognosis, but a correct preoperative diagnostic and therapeutic management provides tools to perform this type of surgery with acceptable morbidity and mortality, thus improving long-term results.

Entities:  

Mesh:

Year:  2013        PMID: 23494083     DOI: 10.1007/s00268-013-1980-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

1.  Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.

Authors:  J N Vauthey; A Chaoui; K A Do; M M Bilimoria; M J Fenstermacher; C Charnsangavej; M Hicks; G Alsfasser; G Lauwers; I F Hawkins; J Caridi
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

2.  Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures.

Authors:  D Erdogan; J J Kloek; F J W ten Kate; E A J Rauws; O R C Busch; D J Gouma; T M van Gulik
Journal:  Br J Surg       Date:  2008-06       Impact factor: 6.939

3.  Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients.

Authors:  Francesca Ratti; Corrado Soldati; Marco Catena; Michele Paganelli; Gianfranco Ferla; Luca Aldrighetti
Journal:  Updates Surg       Date:  2010-11-30

4.  Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival.

Authors:  T M van Gulik; J J Kloek; A T Ruys; O R C Busch; G J van Tienhoven; J S Lameris; E A J Rauws; D J Gouma
Journal:  Eur J Surg Oncol       Date:  2010-11-27       Impact factor: 4.424

5.  Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.

Authors:  Y Nimura; J Kamiya; S Kondo; M Nagino; K Uesaka; K Oda; T Sano; H Yamamoto; N Hayakawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

Review 6.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

7.  Liver dysfunction and sepsis determine operative mortality after liver resection.

Authors:  L Capussotti; L Viganò; F Giuliante; A Ferrero; I Giovannini; G Nuzzo
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

8.  Minimally invasive approaches to extrapancreatic cholangiocarcinoma.

Authors:  Andrew A Gumbs; Nicolas Jarufe; Brice Gayet
Journal:  Surg Endosc       Date:  2012-08-28       Impact factor: 4.584

9.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

10.  Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.

Authors:  Margo Shoup; Mithat Gonen; Michael D'Angelica; William R Jarnagin; Ronald P DeMatteo; Lawrence H Schwartz; Scott Tuorto; Leslie H Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

View more
  17 in total

1.  Delay in surgical treatment of patients with hilar cholangiocarcinoma: does time impact outcomes?

Authors:  Anthony T Ruys; Simon G Heuts; Eric A Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2013-08-26       Impact factor: 3.647

Review 2.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

3.  Laparoscopic major hepatectomies: current trends and indications. A comparison with the open technique.

Authors:  Francesca Ratti; Federica Cipriani; Riccardo Ariotti; Fabio Giannone; Michele Paganelli; Luca Aldrighetti
Journal:  Updates Surg       Date:  2015-07-02

Review 4.  Preoperative biliary drainage in hilar cholangiocarcinoma: When and how?

Authors:  Woo Hyun Paik; Nerenthran Loganathan; Jin-Hyeok Hwang
Journal:  World J Gastrointest Endosc       Date:  2014-03-16

Review 5.  Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma.

Authors:  Federica Cipriani; Francesca Ratti; Guido Fiorentini; Raffaella Reineke; Luca Aldrighetti
Journal:  Updates Surg       Date:  2021-02-22

Review 6.  [Perihilar cholangiocarcinoma (Klatskin tumor)].

Authors:  G A Stavrou; M Donati; S Faiss; R M Jenner; K J Niehaus; K J Oldhafer
Journal:  Chirurg       Date:  2014-02       Impact factor: 0.955

7.  [Klatskin tumor: long-term survival following surgery].

Authors:  B Juntermanns; C D Fingas; G C Sotiropoulos; D Jaradat; A Dechêne; H Reis; S Kasper; A Paul; G M Kaiser
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

8.  Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study.

Authors:  Amber L Simpson; Lauryn B Adams; Peter J Allen; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; T Peter Kingham; Universe Leung; Michael I Miga; E Patricia Parada; William R Jarnagin; Richard K G Do
Journal:  J Am Coll Surg       Date:  2014-12-07       Impact factor: 6.113

9.  Best options for preoperative biliary drainage in patients with Klatskin tumors.

Authors:  Jung Hyun Jo; Moon Jae Chung; Dai Hoon Han; Jeong Youp Park; Seungmin Bang; Seung Woo Park; Si Young Song; Jae Bock Chung
Journal:  Surg Endosc       Date:  2016-06-10       Impact factor: 4.584

10.  Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor?

Authors:  Francesca Ratti; Federica Cipriani; Guglielmo Piozzi; Marco Catena; Michele Paganelli; Luca Aldrighetti
Journal:  J Gastrointest Surg       Date:  2015-05-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.